Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Deciphera Pharmaceuticals as a limited distribution partner for new drug QINLOCKTM (ripretinib). QINLOCK™ is a kinase inhibitor indicated for the...

Read the Official PANTHERx Press Release. PANTHERx Rare Pharmacy (PANTHERx) has again been recognized as the winner of the annual, national Specialty Pharmacy Patient Choice Award™. “We are honored and humbled to be recognized as the top independent specialty...

Read the Official PANTHERx Press Release. In a landmark, non-commercial publication available for download, PANTHERx Rare Pharmacy explores the details of how changes in U.S. Federal policy and advances in scientific research have led to the dawn of medical...

Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Blueprint Medicines Corporation as a very limited distribution partner for breakthrough drug AYVAKIT™ (avapritinib). It has been approved for the...

PANTHERx® Rare Pharmacy announces that it has been selected by Harmony Biosciences, LLC (Harmony) to distribute WAKIX® (pitolisant). PANTHERx is one of a select few specialty pharmacies providing nationwide access to the medication. “We are excited to...

Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals as a very limited distribution partner for the novel drug GIVLAARI™ (givosiran). GIVLAARI is the first and only FDA-approved...